Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma. (Record no. 8629984)

MARC details
000 -LEADER
fixed length control field 01318 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513090738.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199607s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0008-543X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.0.CO;2-4
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Legha, S S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19960701
245 00 - TITLE STATEMENT
Title Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer
Date of publication, distribution, etc. Jan 1996
300 ## - PHYSICAL DESCRIPTION
Extent 89-96 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infusions, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-2
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gianan, M A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Plager, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eton, O E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Papadopoulous, N E
773 0# - HOST ITEM ENTRY
Title Cancer
Related parts vol. 77
-- no. 1
-- p. 89-96
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.0.CO;2-4">https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.0.CO;2-4</a>
Public note Available from publisher's website

No items available.